UPC CFI 108/2026

Jan 12, 2026·EP2493466: NOVEL ANTITUMORAL USE OF CABAZITAXEL

Case details: Status
Case Closed
Action
Other
Category
Other Procedural
Parties: Claimants
STADA Arzneimittel AG
STADA Nordic ApS
STADAPHARM GmbH
Reps: Konstantin Schallmoser
Respondents
Sanofi-Aventis Deutschland GmbH
Sanofi Mature IP
Sanofi B.V.
Sanofi S.r.l.
Sanofi Winthrop Industrie
Sanofi-Aventis France
Sanofi Belgium
Sanofi-Aventis GmbH
Sanofi - Produtos Farmaceuticos Lda
Sanofi AB
Sanofi A/S
Reps: Frédéric Chevallier
Division: Munich LD
Judges: Matthias Zigann
Tobias Pichlmaier
Alima Zana
Technology: Pharmaceutical & Medical
Language: English

Documents

Document title	Date	Public
action.publishOrderDecision.case	2026-02-23	Not public
action.phaseChange.caseClose	2026-02-13	Not public
Receipt	2026-01-12	Not public
Cover sheet	2026-01-12	Not public
Exhibit document Applicant	2026-01-12	Not public
Exhibit document Applicant	2026-01-12	Not public
Exhibit document Applicant	2026-01-12	Not public
Exhibit document Applicant	2026-01-12	Not public
Application document Applicant	2026-01-12	Not public